FDA Safety Information and Adverse Event Reporting
Methotrexate Sodium, USP Injectable Vials by Sandoz US: Recall - Particulate Matter In Vials
Abbott Diabetes Care: Class 1 Recall - FreeStyle InsuLinx Blood Glucose Meters - Risk of Incorrect Test Result
All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility: Recall - Lack Of Sterility Assurance
Compounded Prescription Therapies By Pentec Health Inc.: Recall - Lack Of Sterility Assurance
Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses
Atriphen dietary supplement (Xymogen brand): Recall - Potential Allergic Reaction Due to Milk and Soy
The Compounding Shop: FDA News Release - Lack of Sterility Assurance of Drug Products
SexVoltz, Velextra, and Amerect by Beomonstar Products: Recall - Undeclared Drug Ingredient
Bullet Proof: Public Notification - Undeclared Drug Ingredient
Lightning Rod Capsules: Recall - Undeclared Drug Ingredient
Maquet SERVO-i Ventilator Battery Module: Class 1 Recall - Battery Run Time Shorter Than Expected
Medtronic: Class 1 Recall - Medtronic Deep Brain Stimulation Lead Kit and Activa Dystonia HDE Kit
Covidien Surgical Stapler Reloads: FDA Safety Communication - Devices Stolen Before They Were Sterilized
Cardinal Health: Class 1 Recall - Various Presource Kits Containing a Pre-Assembled Anesthesia Circuit
Valproate Anti-Seizure Products: Drug Safety Communication - Contraindicated for Pregnant Women for Prevention of Migraine Headaches
Kadcyla (ado-trastuzumab emtansine): Drug Safety Communication - Potential Medication Errors Resulting from Name Confusion
American Lifestyle Vicerex and Black Ant Capsules: Recall - Undeclared Drug Ingredient
Hospira Inc., GemStar Infusion System: Recall - Lithium Battery Low Voltage
Newport Medical Instruments, Inc., HT70 and HT70 Plus Ventilators: Class I Recall - Unit Goes Into Internal Backup Battery Sooner Than Expected
Anticoagulant Citrate Phosphate Dextrose Solution, USP (CPD) BLOOD-PACK Unit By Fenwal: Recall - Labeling Issue Identified

FDA Safety Information and Adverse Event Reporting

Description

May 14, 2013
UPDATED 05/14/2013. FDA has approved label changes specifying new dosing recommendations for zolpidem products.
Web Link

FDA Safety Information and Adverse Event Reporting is a sample topic found in Davis's Drug Guide.

To find other Davis's Drug Guide topics please log in or purchase a subscription.

Content Manager